SHANDA FELTON: Open Payments
NPI 1972161503 · FUQUAY VARINA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 44 payments from 12 companies in 2025. Trend: 2023 $1,169 · 2024 $1,881 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $223 |
| Vanda Pharmaceuticals Inc. | 8 | $201 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Alkermes, Inc. | 4 | $76 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Tris Pharma Inc | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
Products named: VRAYLAR, FANAPT, REXULTI, HETLIOZ, ARISTADA, Auvelity, TRINTELLIX, Jornay PM.
Industry payments across NC — which companies pay providers there.
